Correlation Between Tekla Healthcare and Emerging Markets

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tekla Healthcare and Emerging Markets at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tekla Healthcare and Emerging Markets into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tekla Healthcare Investors and Emerging Markets Equity, you can compare the effects of market volatilities on Tekla Healthcare and Emerging Markets and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tekla Healthcare with a short position of Emerging Markets. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tekla Healthcare and Emerging Markets.

Diversification Opportunities for Tekla Healthcare and Emerging Markets

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Tekla and Emerging is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Tekla Healthcare Investors and Emerging Markets Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emerging Markets Equity and Tekla Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tekla Healthcare Investors are associated (or correlated) with Emerging Markets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emerging Markets Equity has no effect on the direction of Tekla Healthcare i.e., Tekla Healthcare and Emerging Markets go up and down completely randomly.

Pair Corralation between Tekla Healthcare and Emerging Markets

Assuming the 90 days horizon Tekla Healthcare is expected to generate 1.38 times less return on investment than Emerging Markets. In addition to that, Tekla Healthcare is 1.52 times more volatile than Emerging Markets Equity. It trades about 0.07 of its total potential returns per unit of risk. Emerging Markets Equity is currently generating about 0.15 per unit of volatility. If you would invest  1,061  in Emerging Markets Equity on June 6, 2025 and sell it today you would earn a total of  72.00  from holding Emerging Markets Equity or generate 6.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tekla Healthcare Investors  vs.  Emerging Markets Equity

 Performance 
       Timeline  
Tekla Healthcare Inv 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Tekla Healthcare Investors are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical indicators, Tekla Healthcare is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Emerging Markets Equity 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Emerging Markets Equity are ranked lower than 11 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Emerging Markets may actually be approaching a critical reversion point that can send shares even higher in October 2025.

Tekla Healthcare and Emerging Markets Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tekla Healthcare and Emerging Markets

The main advantage of trading using opposite Tekla Healthcare and Emerging Markets positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tekla Healthcare position performs unexpectedly, Emerging Markets can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emerging Markets will offset losses from the drop in Emerging Markets' long position.
The idea behind Tekla Healthcare Investors and Emerging Markets Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Managers
Screen money managers from public funds and ETFs managed around the world